Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
221 CHF | +1.01% | -0.50% | -9.61% |
Apr. 26 | Roche: positive CHMP opinion for Alecensa | CF |
Apr. 26 | Roche’s Lung Cancer Drug Alecensa Backed for Approval in EU | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.61% | 193B | |
+25.83% | 653B | |
+27.00% | 556B | |
-6.76% | 354B | |
+20.34% | 331B | |
+3.00% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-6.26% | 144B | |
-11.77% | 143B |
- Stock Market
- Equities
- ROG Stock
- News Roche Holding AG
- Transcript : Roche Holding AG, Q1 2022 Sales/ Trading Statement Call, Apr 25, 2022